title: Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.
abstract: On February 2, 2015, the Rhode Island Department of Health was notified of a case of meningococcal disease in a male undergraduate student at Providence College. Three days later, a second case was reported in a male undergraduate with no contact with the first student, indicating an attack rate of 44 cases per 100,000 students, nearly 500 times higher than the national incidence of 0.15 cases per 100,000 among persons aged 17-22 years (Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, unpublished data, 2013). Both cases were caused by a rare outbreak strain of Neisseria meningitidis serogroup B (ST-9069); neither case was fatal. In response to the outbreak, potential contacts received antibiotic chemoprophylaxis, and a mass vaccination campaign with a recently licensed serogroup B meningococcal (MenB) vaccine was implemented. In collaboration with CDC, the first phase of a meningococcal carriage evaluation was undertaken.
authors.forename: Heidi M
authors.initials: HM
authors.lastname: Soeters
authors.forename: Lucy A
authors.initials: LA
authors.lastname: McNamara
authors.forename: Melissa
authors.initials: M
authors.lastname: Whaley
authors.forename: Xin
authors.initials: X
authors.lastname: Wang
authors.forename: Nicole
authors.initials: N
authors.lastname: Alexander-Scott
authors.forename: Koren V
authors.initials: KV
authors.lastname: Kanadanian
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Kelleher
authors.forename: Jessica
authors.initials: J
authors.lastname: MacNeil
authors.forename: Stacey W
authors.initials: SW
authors.lastname: Martin
authors.forename: Nathan
authors.initials: N
authors.lastname: Raines
authors.forename: Steven
authors.initials: S
authors.lastname: Sears
authors.forename: Cynthia
authors.initials: C
authors.lastname: Vanner
authors.forename: Jeni
authors.initials: J
authors.lastname: Vuong
authors.forename: Utpala
authors.initials: U
authors.lastname: Bandy
authors.forename: Kenneth
authors.initials: K
authors.lastname: Sicard
authors.forename: Manisha
authors.initials: M
authors.lastname: Patel
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000453:epidemiology*; D002939:Ciprofloxacin / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000517:prevention & control*; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D032541:Mass Vaccination; D008589:Meningococcal Infections / Q000453:epidemiology* / Q000382:microbiology* / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000008:administration & dosage; D038541:Neisseria meningitidis, Serogroup B / Q000302:isolation & purification*; D012237:Rhode Island / Q000453:epidemiology; D014495:Universities; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines; D002939:Ciprofloxacin